Approval · Notice of Compliance 35449 · 2025
LANCORA: Notice of Compliance 35449
Issued May 30, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35449
- Date
- May 30, 2025
- Company
- Servier Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product Monograph reformatted to the Master Template. Update to package labels
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LANCORA | Not yet assigned | — |
Medicinal ingredients
- IVABRADINE HYDROCHLORIDE 7.5 MG per TAB
- IVABRADINE HYDROCHLORIDE 5 MG per TAB